Evidence map›Paper›PMID 22681958›Full record

ArticleBMC microbiology2012

An important role of interleukin-10 in counteracting excessive immune response in HT-29 cells exposed to Clostridium butyricum.

Quanxin Gao, Lili Qi, Tianxing Wu, Jinbo Wang

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Uncovering the mechanism ofFrontiers in microbiology · 2024
    Article
  3. Effects of dietaryFrontiers in immunology · 2023
    Article
  4. Inhibitory effects ofFrontiers in immunology · 2023
    Article
  5. Effects of Probiotics on Growth and Immunity of Piglets.Animals : an open access journal from MDPI · 2022
    Article
  6. Article
  7. Frontiers in veterinary science · 2021
    Article
  8. Frontiers in cellular and infection microbiology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Effect ofFrontiers in microbiology · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Quanxin GaoKey Laboratory for Molecular Design and Nutrition Engineering, Ningbo Institute of Technology, Zhejiang University, No, 1 Qianhunan Road, Ningbo, 315100, China.
Lili Qi
Tianxing Wu
Jinbo Wang
Ningbo University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClostridium butyricum has become increasingly important in preventing and treating intestinal inflammation. In the intestine it may increase the resistance of the gut to pathogen invasion via inducing the secretion of anti-inflammatory cytokines. Interleukin 10 (IL-10) plays a central role in preventing certain inflammatory diseases by down-regulating inflammatory cascades. In a previous study, we observed that the level of IL-10 mRNA was modulated by C. butyricum. The aim of this study was to investigate whether C. butyricum achieves its beneficial effects through IL-10.

resultsWe treated HT-29 cells with anti-IL-10 (IL-10 antibody) or siIL-10 (IL-10 small interfering RNA) to disrupt IL-10. In both cases, the effects of C. butyricum-induced NF-κB activation and IL-8 expression were enhanced. We also found that neutralization or knockdown of IL-10 could induce apoptosis and necrosis of HT-29 cells treated with C. butyricum compared with control cells.

conclusionsThese findings show that IL-10 serves an important role in C. butyricum-mediated immune protection, and in host recognition of C. butyricum.

Indexed as

ApoptosisClostridium butyricumEpithelial CellsHT29 CellsHumansInterleukin-10Interleukin-10

Identifiers

PMID22681958
PMCPMC3410821
OpenAlexW2036252702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.